• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

TeraRecon previews treatment planning software

Article

Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose

Japanese postprocessing firm TeraRecon demonstrated work-in-progress treatment planning software at the ASTRO meeting Nov. 4 to 8. The software, which runs on TeraRecon’s Aquarius workstation, supports treatment planning, dose calculation, and dose optimization. It features real-time 3-D volume rendering, using the company’s VolumePro technology, as well as such advanced features as interactive image fusion, auto contouring, beam and block entry, dose calculation, and segmented image reconstruction with isodose display. The system can also digitally reconstruct radiographs and generate dose-volume histograms for 3-D structures. An intravascular brachytherapy module provides extended radial and anisotropic dose functions.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.